Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-06T23:18:21.447Z Has data issue: false hasContentIssue false
  • English
  • Français

Synthesis and X-ray powder diffraction data of 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b]azepine

Published online by Cambridge University Press:  13 March 2013

M. A. Macías ,
J. A. Henao ,
Lina María Acosta  and
Alirio Palma
M. A. Macías
Affiliation:
Grupo de Investigación en Química Estructural (GIQUE), Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, A.A. 678, Carrera 27, Calle 9 Ciudadela Universitaria, Bucaramanga, Colombia
J. A. Henao*
Affiliation:
Grupo de Investigación en Química Estructural (GIQUE), Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, A.A. 678, Carrera 27, Calle 9 Ciudadela Universitaria, Bucaramanga, Colombia
Lina María Acosta
Affiliation:
Laboratorio de Síntesis Orgánica (LSO), Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, A.A. 678, Carrera 27, Calle 9, Ciudadela Universitaria, Bucaramanga, Colombia
Alirio Palma
Affiliation:
Laboratorio de Síntesis Orgánica (LSO), Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, A.A. 678, Carrera 27, Calle 9, Ciudadela Universitaria, Bucaramanga, Colombia
*
a)Author to whom correspondence should be addressed. Electronic mail: jahenao@uis.edu.co

Abstract

The stereoselective synthesis of 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b]azepine was developed by intramolecular 1,3-dipolar cycloaddition of the nitrone derived from the corresponding 2-allyl-4-fluoro-N-(3-methylbut-2-enyl)aniline. The X-ray powder diffraction (XRPD) pattern for the new compound was analyzed and found to crystallize in a monoclinic system with space group P21/m (No. 11) and refined unit-cell parameters a = 11.655(5) Å, b = 5.850(2) Å, c = 18.314(4) Å, β = 104.27(3) and V = 1210.1 (6) Å3.

Keywords

1, 4-Epoxytetrahydrobenzoazepinesantiparasitic activityX-ray powder diffraction data

Information

Type
New Diffraction Data
Information
Powder Diffraction , Volume 28 , Issue 1 , March 2013 , pp. 49 - 52
Copyright
Copyright © International Centre for Diffraction Data 2013 

I. INTRODUCTION

Previously, we have described a simple and efficient synthetic pathway to obtain a wide range of new substituted 1,4-epoxy-2,3,4,5-tetrahydro-1-benzazepines and their reduced 2,3,4,5-tetrahydrobenzo[b]azepin-4-ols starting from appropriate N-substituted ortho-allylanilines (Gómez-Ayala et al., Reference Gómez-Ayala, Stashenko, Palma, Bahsas and Amaro-Luis2006; Acosta et al., Reference Acosta, Palma and Bahsas2010). Compounds of this type showed promising activity in vitro against Trypanosoma cruzi and Leishmania chagasi parasites (Palma et al., Reference Palma, Yépes, Leal, Coronado and Escobar2009; Gómez-Ayala et al., Reference Gómez-Ayala, Stashenko, Palma, Bahsas and Amaro-Luis2006, Reference Gómez-Ayala, Castrillón, Palma, Leal, Escobar and Bahsas2010). As a continuation of our structural study of 2-substituted 1,4-epoxytetrahydro-1-benzazepines and as part of a program to identify structurally novel antiparasitic compounds with new modes of action to combat both T. cruzi and L. chagasi, here we report the synthesis and the X-ray powder diffraction (XRPD) data of the new compound 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b]azepine.

The synthesis of this compound involved treating the corresponding 2-allyl-4-fluoro-N-(3-methylbut-2-enyl)aniline with an excess of hydrogen peroxide solution in the presence of catalytic amounts of sodium tungstate, and subsequent internal 1,3-dipolar cycloaddition of the resulting nitrone across the terminal C = C bond of the pendant allylic fragment, according to the methodology reported by Murahashi et al. (Reference Murahashi, Mitsui, Shiota, Tsuda and Watanabe1990).

II. EXPERIMENTAL

A. Synthesis

For the preparation of the title compound (Figure 1), sodium tungstate dihydrate (10 mol% Na2WO4.2H2O), followed by 30% aqueous hydrogen peroxide solution (30 mmol), were added to a stirred and cooled (ice-bath) solution of the 2-allyl-4-fluoro-N-(3-methylbut-2-enyl)aniline (10 mmol), 1a, in methanol (30 ml). The resulting mixture was stirred at 0 °C for 2 h and then at room temperature for an additional 6 h. The mixture was filtered and then extracted with ethyl acetate and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure and toluene (30 ml) was added to the organic black residue. The resulting solution was heated at reflux for 7 h. After cooling the solution to ambient temperature, the solvent was removed under reduced pressure and the crude product was purified by chromatography on silica gel using heptane-ethyl acetate (compositions in the range from 50:1 to 2:1 v/v) as eluent. The new compound 2a (M.p. 72 °C) was obtained as a colorless solid with a 35% yield.

Figure 1.

Synthesis of the 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b]azepine.

B. Powder data collection

A small amount of the new compound C14H16FNO was gently ground in an agate mortar and sieved to a grain size of less than 38 μm. The specimen was mounted on a zero-background specimen holder (Buhrke et al., Reference Buhrke, Jenkins and Smith1998) for the respective measurement. The XRPD data were collected at 295 K with a D8 FOCUS BRUKER diffractometer operating in Bragg-Brentano geometry equipped with an X-ray tube (CuKα radiation: λ = 1.5406 Å, 40 kV, and 40 mA) using a nickel filter and a one-dimensional LynxEye detector. A fixed antiscatter slit of 8 mm, receiving slit of 1 mm, soller slits of 2.5°, and a detector slit of 3 mm were used. The scan range was from 2 to 70 °2θ with a step size of 0.02 °2θ and a counting time of 0.4 s per step.

POWDERX program (Dong, Reference Dong1999) was used to remove the background (Sonneveld and Visser, Reference Sonneveld and Visser1975), smoothing (Savitzky and Golay, Reference Savitzky and Golay1964) to eliminate the Kα 2 component (Rachinger, Reference Rachinger1948), and the second derivative method was used to determine the positions and intensities of the diffraction peaks.

III. RESULTS AND DISCUSSION

The XRPD pattern of 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b]azepine is shown in Figure 2 and the data for this compound are given in Table I. The XRPD pattern was successfully indexed using the DICVOL06 program (Boultif and Loüer, Reference Boultif and Loüer2006) on a monoclinic cell with an absolute error of ±0.03°2θ in the calculations. The space group, P21/m (No. 11) was estimated by the CHEKCELL program (Laugier and Bochu, Reference Laugier and Bochu2002), which was compatible with the systematic absence and with the crystal density, 1.243 g cm−3. The unit-cell parameters were refined with the NBS*AIDS83 program (Mighell et al., Reference Mighell, Hubbard and Stalick1981). The crystal data, X-ray density as well as figures of merit M 20 (de Wolff, Reference de Wolff1968) and F 30 (Smith and Snyder, Reference Smith and Snyder1979) are compiled in Table II.

Figure 2.

XRPD pattern of 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b]azepine.

Table I.

XRPD data of 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b] azepine.

Table II.

Crystal-structure data for 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b] azepine.

ACKNOWLEDGEMENTS

This work was partially supported by Colciencias (Grant No. 1102-521-28229). The authors would like to acknowledge Miguel A. Ramos from Instituto Zuliano de Investigaciones Tecnológicas, INZIT (Maracaibo-Venezuela) for data collection. M.A. Macías and L.M. Acosta thank Colciencias for their doctoral fellowships.

References

Acosta, L. M., Palma, A., and Bahsas, A. (2010). “Rational use of substituted N-allyl and N,N-diallylanilines in the stereoselective synthesis of novel 2-alkenyltetrahydro-1-benzazepines,” Tetrahedron 66, 8392–8401.CrossRefGoogle Scholar
Boultif, A. and Loüer, D. (2006). “Indexing of powder diffraction patterns of low symmetry lattices by successive dichotomy method,” J. Appl. Crystallogr. 37, 724–731.CrossRefGoogle Scholar
Buhrke, V., Jenkins, R., and Smith, D. (1998). Preparation of Specimens for X-ray Fluorescence and X-ray Diffraction Analysis (Wiley, New York), pp. 141–142.Google Scholar
de Wolff, P. M. (1968). “A simplified criterion for the reliability of a powder pattern indexing,” J. Appl. Crystallogr. 1, 108–113.CrossRefGoogle Scholar
Dong, C. (1999). “POWDERX: Windows 95 based program for powder X-ray diffraction data processing,” J. Appl. Crystallogr. 32, 833–838.CrossRefGoogle Scholar
Gómez-Ayala, S., Castrillón, J. A., Palma, A., Leal, S. M., Escobar, P., and Bahsas, A. (2010). “Synthesis, structural elucidation and in vitro antiparasitic activity against Trypanosoma cruzi and Leishmania chagasi parasites of novel tetrahydro-1-benzazepine derivatives,” Bioorg. Med.Chem. 18, 4721–4739.CrossRefGoogle ScholarPubMed
Gómez-Ayala, S. L., Stashenko, E., Palma, A., Bahsas, A., and Amaro-Luis, J. M. (2006). “Sequential amino-claisen rearrangement/intramolecular 1,3-dipolar cycloaddition/reductive cleavage approach to the stereoselective synthesis of cis-4-hydroxy-2-aryl-2,3,4,5-tetrahydro-1(1H)-benzazepines,” Synlett 14, 2275–2277.Google Scholar
Laugier, J. and Bochu, B. (2002). CHEKCELL. LMGP-Suite Suite of Programs for the Interpretation of X-ray. Experiments, ENSP/Laboratoire des Matériaux et du Génie Physique, BP 46. 38042 Saint Martin d'Hères, France. http://www.inpg.fr/LMGP and http://www.ccp14.ac.uk/tutorial/lmgp/Google Scholar
Mighell, A. D., Hubbard, C R., and Stalick, J. K. (1981). NBS* AIDS83: A FORTRAN Program for Crystallographic Data Evaluation, National Bureau of Standards (USA), Technical Note 1141.CrossRefGoogle Scholar
Murahashi, S. I., Mitsui, H., Shiota, T., Tsuda, T., and Watanabe, S. (1990). “Tungstate-catalyzed oxidation of secondary amines to nitrones. α-Substitution of secondary amines via nitrones,” J. Org. Chem. 55, 1736–1744.CrossRefGoogle Scholar
Palma, A., Yépes, A. F., Leal, S. M., Coronado, C. A., and Escobar, P. (2009). “Synthesis and in vitro activity of new tetrahydronaphtho[1,2-b]azepine derivatives against Trypanosoma cruzi and Leishmania chagasi parasites,” Bioorg. Med. Chem. Lett. 19, 2360–2363.CrossRefGoogle ScholarPubMed
Rachinger, W. A. (1948). “A correction for the α 1α 2 doublet in the measurement of widths of X-ray diffraction lines,” J. Sci. Instrum. 25, 254–255.CrossRefGoogle Scholar
Savitzky, A. and Golay, M. J. (1964). “Smoothing and differentiation of data by simplified least squares procedures,” Anal. Chem. 36, 1627–1639.CrossRefGoogle Scholar
Smith, G. S. and Snyder, R. L. (1979). “F N: A criterion for rating powder diffraction patterns and evaluating the reliability of powder-pattern indexing,” J. Appl. Crystallogr. 12, 60–65.CrossRefGoogle Scholar
Sonneveld, E. J. and Visser, J. W. (1975). “Automatic collection of powder diffraction data from photographs,” J. Appl. Crystallogr. 8, 1–7.CrossRefGoogle Scholar
Figure 0

Figure 1. Synthesis of the 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b]azepine.

Figure 1

Figure 2. XRPD pattern of 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b]azepine.

Figure 2

Table I. XRPD data of 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b] azepine.

Figure 3

Table II. Crystal-structure data for 7-fluoro-2-exo-(2-methylpropen-1-yl)-2,3,4,5-tetrahydro-1,4-epoxybenzo[b] azepine.